Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinji Shimada

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
Frontiers in Immunology|September 5, 2022
Characterization of human epithelial resident memory regulatory T cellsTakuya Sato, Youichi Ogawa, Kazunori Yokoi, et al.
The Journal of Investigative Dermatology|November 30, 2012
Therapeutic potential of B and T lymphocyte attenuator expressed on CD8+ T cells for contact hypersensitivityDaiki Nakagomi, Kotaro Suzuki, Junichi Hosokawa, et al.
Bioorganic & Medicinal Chemistry Letters|March 6, 2019
Discovery of NR2B-selective antagonists via scaffold hopping and pharmacokinetic profile optimizationKosuke Anan, Moriyasu Masui, Aya Tazawa, et al.
The Journal of Dermatology|January 21, 2014
Epstein-Barr virus-associated T/natural killer-cell lymphomas in the elderly: the first consensus meeting in Kofu 2013Toshihisa Hamada, Shigeo Nakamura, Young-Hyeh Ko, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2005
Carbonic anhydrase II is a tumor vessel endothelium-associated antigen targeted by dendritic cell therapyKenta Yoshiura, Takashi Nakaoka, Toshihide Nishishita, et al.
Bioorganic & Medicinal Chemistry Letters|May 29, 2018
Pyrrolinone derivatives as a new class of P2X3 receptor antagonists. Part 1: Initial structure-activity relationship studies of a hit from a high throughput screeningHiroyuki Tobinaga, Takayuki Kameyama, Miho Oohara, et al.
Neuroscience Letters|June 23, 2020
The antagonistic activity profile of naloxone in μ-opioid receptor agonist-induced psychological dependenceAtsushi Nakamura, Kana Yasufuku, Shinji Shimada, et al.
Science Translational Medicine|July 1, 2021
Neutrophils initiate and exacerbate Stevens-Johnson syndrome and toxic epidermal necrolysisManao Kinoshita, Youichi Ogawa, Natsumi Hama, et al.
Journal of Pharmacological Sciences|September 5, 2009
Morphine, oxycodone, and fentanyl exhibit different analgesic profiles in mouse pain modelsKazuhisa Minami, Minoru Hasegawa, Hisanori Ito, et al.
Melanoma Research|September 27, 2003
Results of a phase I clinical study using autologous tumour lysate-pulsed monocyte-derived mature dendritic cell vaccinations for stage IV malignant melanoma patients combined with low dose interleukin-2Hitomi Nagayama, Katsuaki Sato, Mariko Morishita, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Frontiers in Immunology|September 5, 2022
Characterization of human epithelial resident memory regulatory T cellsTakuya Sato, Youichi Ogawa, Kazunori Yokoi, et al.
The Journal of Investigative Dermatology|November 30, 2012
Therapeutic potential of B and T lymphocyte attenuator expressed on CD8+ T cells for contact hypersensitivityDaiki Nakagomi, Kotaro Suzuki, Junichi Hosokawa, et al.
Bioorganic & Medicinal Chemistry Letters|March 6, 2019
Discovery of NR2B-selective antagonists via scaffold hopping and pharmacokinetic profile optimizationKosuke Anan, Moriyasu Masui, Aya Tazawa, et al.
The Journal of Dermatology|January 21, 2014
Epstein-Barr virus-associated T/natural killer-cell lymphomas in the elderly: the first consensus meeting in Kofu 2013Toshihisa Hamada, Shigeo Nakamura, Young-Hyeh Ko, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2005
Carbonic anhydrase II is a tumor vessel endothelium-associated antigen targeted by dendritic cell therapyKenta Yoshiura, Takashi Nakaoka, Toshihide Nishishita, et al.
Bioorganic & Medicinal Chemistry Letters|May 29, 2018
Pyrrolinone derivatives as a new class of P2X3 receptor antagonists. Part 1: Initial structure-activity relationship studies of a hit from a high throughput screeningHiroyuki Tobinaga, Takayuki Kameyama, Miho Oohara, et al.
Neuroscience Letters|June 23, 2020
The antagonistic activity profile of naloxone in μ-opioid receptor agonist-induced psychological dependenceAtsushi Nakamura, Kana Yasufuku, Shinji Shimada, et al.
Science Translational Medicine|July 1, 2021
Neutrophils initiate and exacerbate Stevens-Johnson syndrome and toxic epidermal necrolysisManao Kinoshita, Youichi Ogawa, Natsumi Hama, et al.
Journal of Pharmacological Sciences|September 5, 2009
Morphine, oxycodone, and fentanyl exhibit different analgesic profiles in mouse pain modelsKazuhisa Minami, Minoru Hasegawa, Hisanori Ito, et al.
Melanoma Research|September 27, 2003
Results of a phase I clinical study using autologous tumour lysate-pulsed monocyte-derived mature dendritic cell vaccinations for stage IV malignant melanoma patients combined with low dose interleukin-2Hitomi Nagayama, Katsuaki Sato, Mariko Morishita, et al.
Pageof 9